发明名称 抗腫瘍剤
摘要 Disclosed is an adjuvant that has an anti-tumor effect and that is used in an ancillary manner with a cancer treatment agent. Specifically, disclosed is an adjuvant that has an anti-tumor effect and that, separately from a cancer treatment agent such as an anti-cancer agent, can cause the effect of the cancer treatment agent to be expressed more effectively. The adjuvant having an anti-tumor effect is formed from eliminating iron from a clinical nutritional supplement and/or a nutritionally balanced food. Separately from the cancer treatment agent such as an anti-cancer agent, by providing an iron chelating agent or a clinical nutritional supplement and/or a nutritionally balanced food that do not contain iron, iron in the blood serum is decreased, and thus it is possible to suppress the actual growth of a tumor, and simultaneously to facilitate angiogenesis.
申请公布号 JP5882889(B2) 申请公布日期 2016.03.09
申请号 JP20120505674 申请日期 2011.03.14
申请人 国立大学法人 岡山大学;医療法人創和会 发明人 大原 利章;高岡 宗徳;猶本 良夫;友野 靖子
分类号 A61K45/00;A61K31/07;A61K31/355;A61K31/375;A61K31/51;A61K33/00;A61K39/395;A61P35/00;A61P43/00 主分类号 A61K45/00
代理机构 代理人
主权项
地址